Personal CFO Solutions LLC Boosts Holdings in Zoetis Inc. (NYSE:ZTS)

Personal CFO Solutions LLC raised its position in Zoetis Inc. (NYSE:ZTS - Free Report) by 21.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 8,552 shares of the company's stock after purchasing an additional 1,516 shares during the quarter. Personal CFO Solutions LLC's holdings in Zoetis were worth $1,393,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently bought and sold shares of ZTS. Atlantic Edge Private Wealth Management LLC boosted its holdings in Zoetis by 482.8% in the 4th quarter. Atlantic Edge Private Wealth Management LLC now owns 169 shares of the company's stock valued at $28,000 after purchasing an additional 140 shares during the last quarter. Darwin Wealth Management LLC acquired a new position in Zoetis in the 3rd quarter valued at about $31,000. First Personal Financial Services acquired a new position in shares of Zoetis in the 3rd quarter worth approximately $33,000. Capital Performance Advisors LLP acquired a new position in shares of Zoetis in the 3rd quarter worth approximately $33,000. Finally, Dunhill Financial LLC lifted its holdings in shares of Zoetis by 80.6% in the 3rd quarter. Dunhill Financial LLC now owns 168 shares of the company's stock worth $33,000 after acquiring an additional 75 shares during the last quarter. 92.80% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Roxanne Lagano sold 326 shares of the firm's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $171.18, for a total value of $55,804.68. Following the completion of the sale, the executive vice president now owns 16,107 shares in the company, valued at approximately $2,757,196.26. This trade represents a 1.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.16% of the stock is owned by company insiders.

Remove Ads

Wall Street Analyst Weigh In

Several equities analysts have recently commented on ZTS shares. Leerink Partners started coverage on shares of Zoetis in a report on Monday, December 2nd. They issued an "outperform" rating and a $215.00 price objective on the stock. StockNews.com upgraded shares of Zoetis from a "hold" rating to a "buy" rating in a report on Friday. UBS Group started coverage on shares of Zoetis in a report on Monday, December 9th. They issued a "neutral" rating and a $196.00 price objective on the stock. Piper Sandler upped their target price on shares of Zoetis from $200.00 to $205.00 and gave the stock an "overweight" rating in a research note on Thursday, February 27th. Finally, Leerink Partnrs raised shares of Zoetis to a "strong-buy" rating in a research note on Monday, December 2nd. One analyst has rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Zoetis has a consensus rating of "Buy" and a consensus price target of $215.90.

Zoetis Stock Up 1.8 %

Shares of NYSE:ZTS traded up $3.09 during trading hours on Friday, reaching $170.34. The stock had a trading volume of 3,296,788 shares, compared to its average volume of 3,274,650. Zoetis Inc. has a 1 year low of $144.80 and a 1 year high of $200.33. The firm's 50 day moving average is $166.72 and its 200-day moving average is $176.74. The company has a debt-to-equity ratio of 1.09, a quick ratio of 1.08 and a current ratio of 1.75. The stock has a market capitalization of $76.28 billion, a price-to-earnings ratio of 31.14, a P/E/G ratio of 2.78 and a beta of 0.94.

Zoetis (NYSE:ZTS - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $1.40 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.03. The firm had revenue of $2.32 billion for the quarter, compared to the consensus estimate of $2.30 billion. Zoetis had a net margin of 26.86% and a return on equity of 53.82%. Research analysts predict that Zoetis Inc. will post 6.07 earnings per share for the current fiscal year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 3rd. Investors of record on Monday, April 21st will be given a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.17%. The ex-dividend date is Monday, April 21st. Zoetis's dividend payout ratio (DPR) is 36.56%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.